ErbB pathway inhibitor AG1478 partially rescues the hair cell regeneration deficiency in gemin3, gemin5, and smn1 mutants.
a Quantification of regenerated hair cells in the AG1478-treated smn1hg104 mutant embryos at 2 days post hair cell ablation. b Quantification of regenerated hair cells in AG1478-treated gemin3hg105 mutant embryos at 2 days post hair cell ablation. c Quantification of regenerated hair cells in lateral line neuromasts in AG1478-treated gemin5hg81 mutant embryos at 2 days post hair cell ablation. The slight reduction in the hair cells of the gemin3hg105 heterozygotes treated with 5 µM of AG1478 could be due to drug toxicity to this genetic background, since it was not observed in the smn1hg104 and gemin5hg81 embryos. Graphs show the mean ± s.e.m. Statistical difference are indicated as: ns, P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001. Analysis for each condition was done with ~40 embryos generated from a single pair of heterozygous carrier parents, ablated hair cells at 5 dpf, and then treated with 0, 2.5, or 5 µM of AG1478 from 5 to 7 dpf.
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ NPJ Regen Med
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if
additional information is required.
Oops. Something went wrong. Please try again later.